FindMyKOL

Steven Sanislo, MD

Enriched profile

Clinical Professor, Ophthalmology · Stanford University School of Medicine

ORCIDNone on fileNPI↗
✓ Itemized profile
Region🇺🇸 Stanford, CA · West · United StatesSpecialtyRetina SpecialistFocusMacular Degeneration (AMD)+1
Active KOLFindMyKOL type: EliteLatest publication2026Online presenceNone verifiedPayments2022–2025NIH fundingNone on fileWhy? →

Steven Sanislo is Clinical Professor, Ophthalmology at Stanford University School of Medicine. ClinicalTrials.gov lists 2 registered studies with this person as an investigator.

Data verified 17 Oct 2026

Overview

Updated 31 Oct 2026

Steven Sanislo, MD, is Clinical Professor, Ophthalmology at Stanford University School of Medicine (Stanford Byers Eye Institute). The public record shows 38 publications with 893 citations (h-index 16), centered on Macular Degeneration (AMD), Retinal Drusen. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 8 companies.

  • Top research focus: Macular Degeneration (AMD)
  • 2 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 8 companies

Generated from the cited public record · current as of 31 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Macular Degeneration (AMD)2 trialsRetinal Drusen1 trial

Research focus

OpenAlex concept fingerprint
Macular Degeneration (AMD)Retinal Drusen

Drugs & molecules

across trials, industry payments and publications
Susvimogeneric · RanibizumabClinical trials—Industry payments5Publications—Vabysmogeneric · FaricimabClinical trials—Industry payments3Publications—Dextenzageneric · DexamethasoneClinical trials—Industry payments1Publications—Eyleageneric · AfliberceptClinical trials—Industry payments1Publications—EYLEA HDClinical trials—Industry payments1Publications—Yutiqgeneric · FluocinoloneClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Genentech USA, Inc.Clinical trials—Industry payments6Alcon Vision LLCClinical trials—Industry payments3Genentech, Inc.Clinical trials—Industry payments2Apellis Pharmaceuticals, Inc.Clinical trials—Industry payments1Biogen, Inc.Clinical trials—Industry payments1EyePoint Pharmaceuticals US, Inc.Clinical trials—Industry payments1Ocular Therapeutix, Inc.Clinical trials—Industry payments1Regeneron Pharmaceuticals, Inc.Clinical trials—Industry payments1Stanford UniversityClinical trials1Industry payments—Steven R. SanisloClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
16h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials ↓
8companies · 2022–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

No public contact details on file. This person's NPPES record doesn't include a practice address or telephone number. Why? →

Clinical trials

Updated 31 Oct 2026

Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 31 Oct 2026

8 companies reported payments to CMS in program years 2022–2025. These are public disclosures, not judgments. The latest:

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Background & recognition

Updated 31 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    University of Michigan School of Medicine

    1991
    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
  • Board certified

    American Board of Ophthalmology (Ophthalmology)

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗

Editorial & leadership roles

journal and society appointments
  • Member

    Retina Society

    2005
    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
  • Member

    American Academy of Ophthalmology

    1998
    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
  • Member

    Association for Research in Ophthalmology

    1998
    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
  • Member

    American Society of Retina Specialists

    1998
    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗

Secondary affiliations

appointments beyond the home institution

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.